NDC product
FLAVOXATE HYDROCHLORIDE
NDC 0574-0115 · Padagis US LLC
Key facts
| Product NDC | 0574-0115 |
|---|---|
| Proprietary name | FLAVOXATE HYDROCHLORIDE |
| Nonproprietary name | FLAVOXATE HYDROCHLORIDE |
| Substances | FLAVOXATE HYDROCHLORIDE |
| Dosage form | TABLET, FILM COATED |
| Route | ORAL |
| Labeler | Padagis US LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA076831 |
| Pharmacologic classes | Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA] |
| Marketing start | Dec 22, 2004 |
| Marketing end | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory